Harmony Biosciences Appoints Glenn Reicin as CFO, Reaffirms Outlook
PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) recently appointed Glenn Reicin as chief financial officer, effective immediately, and reaffirmed its 2026 net product revenue guidance of $1.0 …
Harmony Biosciences Appoints Glenn Reicin as CFO, Reaffirms Outlook Read More